The table below shows Entera Bio Ltd.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$7.37M
-$6.82M
-$7.31M
-$12.50M
-$9.06M
-$10.56M
Capital expenditure
$107.00K
$3.00K
$17.00K
$47.00K
$17.00K
$53.00K
Investing cash flow
-$107.00K
-$3.00K
-$17.00K
-$102.00K
-$17.00K
-$53.00K
Dividends paid
-
-
-
-
ENTX operating cash flow (10-K history)
Entera Bio Ltd. reported operating cash flow of -$7.37M for fiscal year 2025. That is down 8.1% from -$6.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$10.56M (FY 2020) to -$7.37M. Figures come from the company's audited annual reports as filed with the SEC.